Bone Medical scores in South Korea
20 June, 2008 by Dylan Bushell-EmblingBone Medical licenses osteoporosis product to Hyundai Pharmaceuticals
HalcyGen sets sights on supergenerics
20 June, 2008 by Dylan Bushell-EmblingHalcyGen talks up booming supergenerics market
BIO 2008: WA kids wow biotech - "thanks for sending only two"
19 June, 2008 by Kate McDonaldTwo West Australian high school students place highly in international biotech competition
BIO 2008: Sharks give malaria the finger
19 June, 2008 by Kate McDonaldSharks become lifesavers - rather than lifesaver-eaters - in Victorian technological research
Cytopia targeting protein kinases
18 June, 2008 by Dylan Bushell-EmblingCytopia to showcase data from FMS inhibitor trial
SCS goes green
18 June, 2008 by Dylan Bushell-EmblingStem Cell Sciences to license green florescent protein technology
ImpediMed opens States-side
18 June, 2008 by Dylan Bushell-EmblingImpediMed opens new manufacturing office in San Diego
BIO 2008: Bananabenders go from bricks to brains
18 June, 2008 by Kate McDonaldQueensland to launch fellowship program as part of Smart State program, Mark III
Bronchitol available to named patients
17 June, 2008 by Dylan Bushell-EmblingIDIS deal to allow patients access to the drug before clinical trials conclude
Proteome completes TB milestone
17 June, 2008 by Dylan Bushell-EmblingProteome Systems step closer to TB diagnostic feasibility
ASIC approves C3 name change
17 June, 2008 by Dylan Bushell-EmblingClinical Cell Culture to trade as Avita Medical from next Thursday
BIO 2008: Optiscan rolls out endoscope
17 June, 2008 by Kate McDonaldOptiscan announces 30-hospital-wide roll out of microendoscope.
Intelliheart tests in Amcal pharmacies
13 June, 2008 by Dylan Bushell-EmblingIM Medical to sell Intelliheart tests through Amcal pharmacies
Pharmaxis concludes Brochitol trial
13 June, 2008 by Dylan Bushell-EmblingPharmaxis to file marketing application pending publication
Genepharm into its Strides
13 June, 2008 by Dylan Bushell-EmblingGenepharm shareholders to vote on Strides business next week
